# A Four-Period, Four-Treatment, Four-Way Relative Bioavailability Study of CL-108 Under Fed and Fasted Conditions

> **NCT02465866** · PHASE1 · COMPLETED · sponsor: **Charleston Laboratories, Inc** · enrollment: 20 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** CL-108
- **DRUG:** Vicoprofen
- **DRUG:** Ultracet
- **DRUG:** Phenergan

## Key facts

- **NCT ID:** NCT02465866
- **Lead sponsor:** Charleston Laboratories, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02465866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02465866, "A Four-Period, Four-Treatment, Four-Way Relative Bioavailability Study of CL-108 Under Fed and Fasted Conditions". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02465866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*